Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wai-Kay Seto

Showing results (251-260 of 326) with videos related to

Pageof 33
Sort By:
Journal of Hepatology|September 19, 2016
Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis BChing-Lung Lai, Danny Wong, Philip Ip, et al.
Plos One|September 10, 2013
Use of liver stiffness measurement for liver resection surgery: correlation with indocyanine green clearance testing and post-operative outcomeJames Fung, Ronnie T P Poon, Wan-Ching Yu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2018
Monitoring and Treatment of Patients Undergoing Immunotherapy With Anti-CD20 Who are Exposed to HBVWai-Kay Seto, Thomas Sau-Yan Chan, Yu-Yan Hwang, et al.
Plos One|June 11, 2014
Artificial neural network accurately predicts hepatitis B surface antigen seroclearanceMing-Hua Zheng, Wai-Kay Seto, Ke-Qing Shi, et al.
JHEP Reports : Innovation in Hepatology|May 3, 2024
Immediate postpartum cessation of tenofovir did not increase risk of virological or clinical relapse in highly viremic pregnant mothers with chronic hepatitis B infectionYu Chen, Lung-Yi Mak, Mary H Y Tang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 12, 2020
Trends in Liver Transplantation for Chronic Hepatitis B in an Era of Highly Potent Antiviral TherapiesJames Fung, Lung-Yi Mak, Albert Chan, et al.
Hepatology International|March 29, 2022
Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinomaRex Wan-Hin Hui, Albert Chi-Yan Chan, Gladys Lo, et al.
Gut|August 8, 2020
Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessationWai-Kay Seto, Kevin Sh Liu, Lung-Yi Mak, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 29, 2019
Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No CirrhosisDanny Ka-Ho Wong, Serene Ching Yan Cheng, Loey Lung-Yi Mak, et al.
The Lancet Regional Health. Western Pacific|July 10, 2023
Shared-care models are highly effective and cost-effective for managing chronic hepatitis B in China: reinterpreting the primary care and specialty divideLei Zhang, Hanting Liu, Zhuoru Zou, et al.
Pageof 33

Showing results (251-260 of 326) with videos related to

Sort By:
Pageof 33
Journal of Hepatology|September 19, 2016
Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis BChing-Lung Lai, Danny Wong, Philip Ip, et al.
Plos One|September 10, 2013
Use of liver stiffness measurement for liver resection surgery: correlation with indocyanine green clearance testing and post-operative outcomeJames Fung, Ronnie T P Poon, Wan-Ching Yu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2018
Monitoring and Treatment of Patients Undergoing Immunotherapy With Anti-CD20 Who are Exposed to HBVWai-Kay Seto, Thomas Sau-Yan Chan, Yu-Yan Hwang, et al.
Plos One|June 11, 2014
Artificial neural network accurately predicts hepatitis B surface antigen seroclearanceMing-Hua Zheng, Wai-Kay Seto, Ke-Qing Shi, et al.
JHEP Reports : Innovation in Hepatology|May 3, 2024
Immediate postpartum cessation of tenofovir did not increase risk of virological or clinical relapse in highly viremic pregnant mothers with chronic hepatitis B infectionYu Chen, Lung-Yi Mak, Mary H Y Tang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 12, 2020
Trends in Liver Transplantation for Chronic Hepatitis B in an Era of Highly Potent Antiviral TherapiesJames Fung, Lung-Yi Mak, Albert Chan, et al.
Hepatology International|March 29, 2022
Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinomaRex Wan-Hin Hui, Albert Chi-Yan Chan, Gladys Lo, et al.
Gut|August 8, 2020
Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessationWai-Kay Seto, Kevin Sh Liu, Lung-Yi Mak, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 29, 2019
Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No CirrhosisDanny Ka-Ho Wong, Serene Ching Yan Cheng, Loey Lung-Yi Mak, et al.
The Lancet Regional Health. Western Pacific|July 10, 2023
Shared-care models are highly effective and cost-effective for managing chronic hepatitis B in China: reinterpreting the primary care and specialty divideLei Zhang, Hanting Liu, Zhuoru Zou, et al.
Pageof 33